Literature DB >> 1525731

Use of medical services and treatment for panic disorder with agoraphobia and for social phobia.

R P Swinson1, B J Cox, C B Woszczyna.   

Abstract

OBJECTIVE: To examine the medical services and treatment for anxiety disorders reported by patients who had either panic disorder with agoraphobia or else social phobia.
DESIGN: Archival research of consecutive records of psychiatric interviews conducted between January 1990 and December 1991. The records were examined by a trained research assistant who had had no contact with the patients. PATIENTS: One hundred patients who had panic disorder with agoraphobia and twenty-eight patients who had social phobia.
SETTING: An anxiety disorders clinic in a university-affiliated psychiatric institute. OUTCOME MEASURES: Variables related to the use of medical services included history of hospitalization, emergency department visits and referrals to specialists. Variables related to treatment included types of medication received, whether behaviour therapy was received and types of health care professionals seen.
RESULTS: Almost 30% of the patients with panic disorder and more than 20% of those with social phobia had a history of a major depressive episode at some time in their lives; 30% and 25% respectively had a current nonpsychiatric medical diagnosis. In the past year nearly one-third of both patient groups had seen three or more different health care professionals and almost one-fifth of those with panic disorder had gone to a general hospital emergency department. Of the patients with panic disorder 9% had previously been assessed by a cardiologist and 17% by a neurologist. At least two-thirds of each group had received benzodiazepines, often for use as needed. Although most of the patients in both groups had been seen by mental health professionals such as psychiatrists, few had received optimal treatment. Of those with panic disorder, only 15% had received the tricyclic antidepressant imipramine, 13% alprazolam and 11% cognitive-behavioural therapy. Only 4% of the patients with social phobia had received cognitive-behavioural therapy.
CONCLUSIONS: Both groups of patients, and particularly those with panic disorder, are frequent users of medical services. Although most have had contact with mental health professionals, few have received appropriate treatment. Benzodiazepines appear to be overprescribed, whereas forms of treatment that have been shown to reduce the use of medical services, such as cognitive-behavioural therapy, are infrequently given.

Entities:  

Mesh:

Year:  1992        PMID: 1525731      PMCID: PMC1336334     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  13 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  Use of medication and in vivo exposure in volunteers for panic disorder research.

Authors:  C B Taylor; R King; J Margraf; A Ehlers; M Telch; W T Roth; W S Agras
Journal:  Am J Psychiatry       Date:  1989-11       Impact factor: 18.112

3.  A survey of anxiety disorders clinics in Canadian hospitals.

Authors:  R P Swinson; B J Cox; S A Kerr; K Kuch; K D Fergus
Journal:  Can J Psychiatry       Date:  1992-04       Impact factor: 4.356

4.  The Mobility Inventory for Agoraphobia.

Authors:  D L Chambless; G C Caputo; S E Jasin; E J Gracely; C Williams
Journal:  Behav Res Ther       Date:  1985

5.  Hypochondriacal fears and beliefs in agoraphobia.

Authors:  G A Fava; R Kellner; M Zielezny; S Grandi
Journal:  J Affect Disord       Date:  1988 May-Jun       Impact factor: 4.839

6.  Use of mental health services for the treatment of panic disorder.

Authors:  J H Boyd
Journal:  Am J Psychiatry       Date:  1986-12       Impact factor: 18.112

7.  Brief treatment of emergency room patients with panic attacks.

Authors:  R P Swinson; C Soulios; B J Cox; K Kuch
Journal:  Am J Psychiatry       Date:  1992-07       Impact factor: 18.112

8.  Recognition, management, and course of anxiety and depression in general practice.

Authors:  J Ormel; M W Koeter; W van den Brink; G van de Willige
Journal:  Arch Gen Psychiatry       Date:  1991-08

9.  Reduction in hypochondriasis with treatment of panic disorder.

Authors:  R Noyes; J Reich; J Clancy; T W O'Gorman
Journal:  Br J Psychiatry       Date:  1986-11       Impact factor: 9.319

10.  Quality of life in panic disorder.

Authors:  J S Markowitz; M M Weissman; R Ouellette; J D Lish; G L Klerman
Journal:  Arch Gen Psychiatry       Date:  1989-11
View more
  9 in total

Review 1.  A review of the epidemiology and approaches to the treatment of social anxiety disorder.

Authors:  L Sareen; M Stein
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

2.  The International Multicenter Clinical Trial Group on Moclobemide in Social Phobia. Moclobemide in social phobia. A double-blind, placebo-controlled clinical study.

Authors: 
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

3.  A pilot open trial of brief psychodynamic psychotherapy for panic disorder.

Authors:  B Milrod; F Busch; A C Leon; A Aronson; J Roiphe; M Rudden; M Singer; T Shapiro; H Goldman; D Richter; M K Shear
Journal:  J Psychother Pract Res       Date:  2001

4.  Panic-focused psychodynamic psychotherapy in a woman with panic disorder and generalized anxiety disorder.

Authors:  Larry Sandberg; Fredric Busch; Franklin Schneier; Andrew Gerber; Eve Caligor; Barbara Milrod
Journal:  Harv Rev Psychiatry       Date:  2012 Sep-Oct       Impact factor: 3.732

5.  Mental disorders in primary care in Israel: prevalence and risk factors.

Authors:  Neil Laufer; Nelly Zilber; Pablo Jecsmien; Binyamin Maoz; Daniel Grupper; Haggai Hermesh; Royi Gilad; Abraham Weizman; Hanan Munitz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-01-04       Impact factor: 4.328

6.  Psychiatric treatment received by primary care patients with panic disorder with and without agoraphobia.

Authors:  Brook A Marcks; Risa B Weisberg; Martin B Keller
Journal:  Psychiatr Serv       Date:  2009-06       Impact factor: 3.084

7.  What treatments do patients with panic disorder and agoraphobia get?

Authors:  B Bandelow; K Sievert; M Röthemeyer; G Hajak; E Rüther
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

8.  Chest pain and its importance in patients with panic disorder: an updated literature review.

Authors:  David A Katerndahl
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

9.  Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder.

Authors:  C François; S A Montgomery; N Despiegel; S Aballéa; J Roïz; P Auquier
Journal:  Int J Clin Pract       Date:  2008-08-28       Impact factor: 2.503

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.